Category Archive: multidrug resistance

Apr 03

Society for Biomaterials – Seattle 2019

Categories:

AD&T Notre Dame, Berthiaume Institute for Precision Health, Combination chemotherapy, Conference abstracts, metastatic cancer cells, multidrug resistance, SFB2019

by

I was in Seattle for the week at the Society for Biomaterials 2019 conference. Excited to have data from three projects in four sessions at SFB 2019. Thanks to CTSI-PDT (#CTSI), ACS-IRG(#americancersociety), NDnano, AD&T and HCRI for their crucial support for these projects. 1. Rapid-Fire oral Presentation on Wednesday on April 3, 2019, from 4:05 …

Continue reading »

Tags: , , ,

Feb 14

Center for the Translational Sciences Indiana Awards us Seed Grant for an Innovative Antibiotic Free Nanotherapeutics to Combat Multi-drug Resistant Bacterial Infections

Categories:

AD&T Notre Dame, antibiotics, Antimicrobial, Berthiaume Institute for Precision Health, Grants funding, multidrug resistance

by

Biomedical research is at risk of losing the antibiotics vs. pathogens arms race. Pneumonia, tuberculosis, gonorrhea, and salmonellosis are becoming harder and sometimes impossible to treat due to the fast emergence and global spread of new antibiotic resistance. Without urgent action, we are heading for a post-antibiotic era, in which common infections and minor injuries …

Continue reading »

Tags:

» Newer posts